Global Community

AFT Pharmaceuticals is a New Zealand-based pharmaceutical business with global ambitions. The company has publicly set a goal of achieving NZ$300 million in revenue by the end of 2027—a target repeated in its 2025 annual report, market release, shareholder letter, and chairman’s address.Read more

Paysauce is finally hitting its stride - now being profitable and showing 32% revenue growth YoY (2023-24) along with the other following Q3 highlights reported January 14th 2025: ARR of $9.1m (Up 11% YoY) Recurring revenue of $2.3m for the quarter (Up 14% YoY) Processing fee revenue of $1.7m for the quarter (Up 19% YoY) Customers at end of the quarter: 8,127 (Up 11% YoY) One can only conclude that the continued growth will continue through 2025 and beyond as interest rates reduce further and the economy restabilises affecting growth within the overall SME market across NZ and other key asia-pac markets. Debt is still low and barely reportable through mainstream channels.Read more

Key Takeaways The company's expansion and reliance on costly air freight impact margins and could pressure revenue if investment returns disappoint. Challenges in key markets, including declining ANZ performance and competition in China, threaten growth amidst costly product launches.Read more

Key Takeaways New leadership is focused on effective governance and strategic alignment, aiming to enhance earnings and shareholder value through transformation efforts. Business reorganization and a strong development pipeline are expected to boost operational efficiency, margins, and future revenue growth through increased capacity.Read more

Key Takeaways Fleet modernization, digitalization, and sustainability initiatives are expected to lower costs, drive efficiency, and strengthen Air New Zealand's competitive position and profitability. Increased premium demand and international tourism growth, especially from the Asia-Pacific region, support stronger yields and future revenue expansion.Read more

Key Takeaways Portfolio focus on sustainable, green-certified industrial assets is driving stronger rental growth, higher valuations, and long-term revenue stability versus non-green assets. Capital recycling and operational efficiencies are enhancing portfolio quality, operating margins, and supporting sustainable long-term earnings growth.Read more

Key Takeaways Product innovation, expansion in hospital and homecare, and operational efficiency are strengthening revenue growth, margin improvement, and pricing power. Global demographic trends and rising healthcare investment are broadening market opportunities and diversifying recurring revenue streams.Read more

Key Takeaways Expanding premium apple focus and growing protein and logistics segments strengthen revenue growth, margin expansion, and earnings resilience. Enhanced sustainability and traceability initiatives improve access to premium markets and mitigate regulatory risks.Read more

Key Takeaways Reliance on Advanced Nutrition sales may lead to slower future growth due to unsustainable restocking and new product launches. Challenges like high fat pricing and unsecured milk supply could pressure margins and impact future profitability and cash flow.Read more